Invention Grant
US08999927B2 Glial cell line-derived neurotrophic factor (GDNF) compositions and use thereof
有权
神经胶质细胞系衍生的神经营养因子(GDNF)组合物及其用途
- Patent Title: Glial cell line-derived neurotrophic factor (GDNF) compositions and use thereof
- Patent Title (中): 神经胶质细胞系衍生的神经营养因子(GDNF)组合物及其用途
-
Application No.: US13855533Application Date: 2013-04-02
-
Publication No.: US08999927B2Publication Date: 2015-04-07
- Inventor: Qing-Rong Liu
- Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Klarquist Sparkman, LLP
- Main IPC: C07K14/47
- IPC: C07K14/47 ; C07K14/475 ; C07K16/22

Abstract:
Described herein is the identification of primate-specific glial cell line-derived neurotrophic factor opposite strand (GDNFOS) transcripts and encoded peptides. In particular embodiments, provided herein are three GDNFOS antisense transcripts, referred to as GDNFOS-1, GDNFOS-2 and GDNFOS-3. The GDNFOS-3 transcript encodes an ORF of 105 amino acids. Compositions comprising the GDNFOS transcripts and peptides are also provided by the present disclosure. Further provided are methods of treating a neurodegenerative or peripheral organ disease in a subject by administering a therapeutically effective amount of the disclosed GDNFOS nucleic acid molecules, peptides or compositions.
Public/Granted literature
- US20130261053A1 GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) COMPOSITIONS AND USE THEREOF Public/Granted day:2013-10-03
Information query